Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2022, 14-16 October 2022, Amsterdam, Netherlands

29 Sep 2022

LUGANO, Switzerland – The Molecular Analysis for Precision Oncology Congress 2022 (MAP) is the yearly appointment where leading experts discuss current and future challenges in the rapidly developing field of precision oncology, with the aim of identifying targetable alterations through molecular profiling, to provide the best possible personalised treatment. The congress will be held in person in Amsterdam, Netherlands, and virtually between 14-16 October.

Programme highlights

  • Addressing the genomic evolution of NSCLC, and real-world data on the efficacy of EGFR tyrosine kinase inhibitors in lung adenocarcinoma
    • Related content: Abstracts 3MO and 12P
  • Moving towards recurrence prediction and (molecular) early detection: new applications and updates on techniques to increase ctDNA test sensitivity
    • Related content: Abstracts 11P, 5MO and 10P
  • Understanding cancer risk: from environmental molecular biology to behavioural lifestyle factors
    • Related content: Session on 16 October 2022, 13:40-15:10 CEST
  • Next-generation sequencing technologies to shape personalised risk predictions and cancer profiling
    • Related content: Session on 14 October 2022, 14:00-17:00 CEST
  • New updates on how to interpretate immunoediting signals by stage in lung cancer
    • Related content: Abstract 2MO

Keynote lectures

The results of more than 140 studies from various parts of the world will be presented and published online as a supplement to Annals of Oncology. The abstract titles can be viewed through the online programme.

Media registration

The MAP organisers welcome media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card. Media representatives are required to observe and abide by the Media Policy. To apply for media accreditation, please fill out the form available here.

Further information

MAP Press Office
press@esmo.org 

MAP is a joint initiative of Cancer Research UK (CRUK), Unicancer and the European Society for Medical Oncology (ESMO). 

Notes to Editors

Please make sure to use the official name of the meeting in your reports: MAP 2022 and the official congress hashtag:  #MAP2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.